Response kinetics and factors predicting survival in core-binding factor leukemia

Leukemia. 2018 Dec;32(12):2698-2701. doi: 10.1038/s41375-018-0158-1. Epub 2018 Jun 8.

Affiliations

¹ Department of Leukemia, MD Anderson Cancer center, Houston, TX, USA.
² UT school of medicine, UT Health sciences, Houston, TX, USA.
³ Department of Hematology, University of British Columbia, Vancouver, BC, Canada.
⁴ Department of Hematopathology, MD Anderson Cancer center, Houston, TX, USA.
⁵ Department of Leukemia, MD Anderson Cancer center, Houston, TX, USA. gborthak@mdanderson.org.

PMID: 29884905
DOI: 10.1038/s41375-018-0158-1

No abstract available

Publication types

Clinical Trial, Phase II
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Antineoplastic Agents / therapeutic use*
Core Binding Factors / metabolism*
Female
Humans
Kinetics
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / metabolism
Leukemia, Myeloid, Acute / mortality*
Male
Middle Aged
Young Adult

Substances

Antineoplastic Agents
Core Binding Factors